INS and metabolic syndrome: In addition, we elucidated the molecular mechanism underlying GnIH-mediated hyperglycemia and dyslipidemia: GnIH disturbed the synthesis of insulin and glucagon in the pancreas as well as fatty acid biosynthesis and fatty acid oxidation in eWAT.